Evidence map›Paper›PMID 41764567›Full record

ArticleJournal of medical case reports2026

Successful treatment of ruptured pseudo-splenic artery aneurysm with endovascular treatment in a hemodynamically stable patient: a case report.

Megu Nara, Masahito Kaji, Yoshitaka Ooya

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Megu NaraDepartment of Emergency and Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
Masahito KajiDepartment of Emergency and Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
Yoshitaka OoyaDepartment of Emergency and Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan. yooya@saitama-med.ac.jp.ORCID http://orcid.org/0000-0001-7057-3080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRuptured pseudo-splenic artery aneurysm is a rare but life-threatening condition, commonly related to pancreatitis or trauma. When spontaneous temporary hemostasis preserves hemodynamics, endovascular therapy may be feasible. CASE PRESENTATION: A 48-year-old Japanese man presented with sudden epigastric pain. On arrival, he had peritoneal signs with preserved blood pressure; hemoglobin was 12.0 g/dL and lactate was 1.31 mmol/L. Contrast-enhanced computed tomography revealed a 40-mm partially thrombosed pseudo-splenic artery aneurysm in the distal splenic artery with hemoperitoneum and pancreatic calcifications consistent with chronic pancreatitis. Emergency endovascular embolization was performed using distal coil embolization followed by proximal injection of 33% N-butyl cyanoacrylate, achieving complete exclusion of the lesion. Blood loss was minimal and no transfusion was required. The patient was discharged on hospital day 22.

conclusionEndovascular embolization can be an effective, minimally invasive option for ruptured pseudo-splenic artery aneurysm when hemodynamics remain stable and treatment is promptly available.

Indexed as

Aneurysm, FalseAneurysm, RupturedEmbolization, TherapeuticEndovascular ProceduresSplenic ArteryAbdominal PainEnbucrilateHemodynamicsHemoperitoneumHumansMaleMiddle AgedTomography, X-Ray ComputedTreatment OutcomeEnbucrilateEmergency managementHemodynamic stabilityInterventional radiologyPseudoaneurysmPseudo-splenic artery aneurysmRuptureTranscatheter arterial embolization

Identifiers

PMID41764567
PMCPMC13059315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.